Multi-criteria decision analysis for assessment and appraisal of orphan drugs
Background: Limited resources and expanding expectations push all countries and types of health systems to adopt new approaches in priority setting and resources allocation. Despite best efforts, it is difficult to reconcile all competing interests and trade-offs are inevitable. This is why multi-cr...
Saved in:
Main Authors: | Georgi Iskrov (Author), Tsonka Miteva-Katrandzhieva (Author), Rumen Stefanov (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2016-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Health economic data in reimbursement of new medical technologies: importance of the socio-economic burden as a decision-making criterion
by: Georgi Iskrov, et al.
Published: (2016) -
Whole-Genome Sequencing in Newborn Screening-Attitudes and Opinions of Bulgarian Pediatricians and Geneticists
by: Georgi Iskrov, et al.
Published: (2017) -
Prospects of risk-sharing agreements for innovative therapies in a context of deficit spending in Bulgaria
by: Georgi eIskrov, et al.
Published: (2015) -
Challenges in mapping European rare disease databases, relevant for ML-based screening technologies in terms of organizational, FAIR and legal principles: scoping review
by: Ralitsa Raycheva, et al.
Published: (2023) -
Socio-Economic Burden of Myasthenia Gravis: A Cost-of-Illness Study in Bulgaria
by: Valentina Ignatova, et al.
Published: (2022)